Clinical trial
Application of Remimazolam Combined With Esketamine in Painless Gastroscopy and Colonoscopy in Elderly Patients
NCT07002801 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Application of Remimazolam Combined With Esketamine in Painless Gastroscopy and Colonoscopy in Elderly Patients
- Lead sponsor
- Harbin Medical University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 14, 2025
- Completion date
- January 31, 2028
- Enrollment
- 280 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastrointestinal disease